Primary Site >> Pancreatic Cancer

Gene >> CXCR4

  • 2000
  • 2003
  • 2004
  • 2005
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression.
PMID: 10999740
Ref: Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo.
PMID: 12761880
Ref: CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer.
PMID: 14749473
Ref: [mRNA expression of chemokine receptors in hepatic and pancreatic tumor cell lines].
PMID: 15332556
Ref: Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4.
PMID: 15548713
Ref: The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer.
PMID: 15662133
Ref: Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma.
PMID: 15978329
Ref: CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer.
PMID: 16230077
Ref: The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis.
PMID: 16300475
Ref: Aberrant methylation of Reprimo correlates with genetic instability and predicts poor prognosis in pancreatic ductal adenocarcinoma.
PMID: 16752411
Ref: Differentiating pancreatic lesions by microarray and QPCR analysis of pancreatic juice RNAs.
PMID: 17012836
Ref: Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease.
PMID: 17089032
Ref: Characterization of the CXCR4 signaling in pancreatic cancer cells.
PMID: 18175225
Ref: Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer.
PMID: 17379424
Ref: Integrin-mediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells.
PMID: 17560257
Ref: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.
PMID: 18371365
Ref: CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer.
PMID: 18349830
Ref: The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia.
PMID: 18664506
Ref: Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.
PMID: 18791122
Ref: Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells.
PMID: 18974138
Ref: Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway.
PMID: 19002187
Ref: CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer.
PMID: 19035451
Ref: Secreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell lines.
PMID: 19064997
Ref: [Expression of CXCL12-CXCR4 and its association with angiogenesis in pancreatic cancer].
PMID: 19615285
Ref: PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression.
PMID: 19784070
Ref: Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways.
PMID: 19820417
Ref: Increased CXCR4 expression in AsPC1 pancreatic carcinoma cells with RNA interference-mediated knockdown of DNMT1 and DNMT3B.
PMID: 19932585
Ref: Integrative genomic analyses of CXCR4: transcriptional regulation of CXCR4 based on TGFbeta, Nodal, Activin signaling and POU5F1, FOXA2, FOXC2, FOXH1, SOX17, and GFI1 transcription factors.
PMID: 20043076
Ref: Pancreatic stellate cells increase the invasion of human pancreatic cancer cells through the stromal cell-derived factor-1/CXCR4 axis.
PMID: 20484957
Ref: Enhanced cell migration and invasion of CD133+ pancreatic cancer cells cocultured with pancreatic stromal cells.
PMID: 20564084
Ref: Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumors.
PMID: 20631070
Ref: Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-kappaB activation in breast and pancreatic tumor cells.
PMID: 20699088
Ref: The molecular mechanisms of traditional Chinese medicine ZHENG syndromes on pancreatic tumor growth.
PMID: 20702498
Ref: High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
PMID: 20732965
Ref: Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor.
PMID: 20798912
Ref: {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.
PMID: 20864511
Ref: CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy.
PMID: 21045835
Ref: Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells.
PMID: 20426768
Ref: The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.
PMID: 20462600
Ref: Acetyl-11-keto-beta-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression.
PMID: 21448932
Ref: Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1alpha-dependent manner in pancreatic cancer cells.
PMID: 21778785
Ref: Holoclone forming cells from pancreatic cancer cells enrich tumor initiating cells and represent a novel model for study of cancer stem cells.
PMID: 21826251
Ref: Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets.
PMID: 22066019
Ref: Molecular pathogenesis of pancreatic cancer and clinical perspectives.
PMID: 22116519
Ref: Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer.
PMID: 22220212
Ref: Treatment of pancreatic cancer: what can we really predict today?
PMID: 24212636
Ref: Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.
PMID: 21935918
Ref: Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells.
PMID: 22294553
Ref: Identification of anti-malarial compounds as novel antagonists to chemokine receptor CXCR4 in pancreatic cancer cells.
PMID: 22319600
Ref: SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway.
PMID: 22450749
Ref: Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients.
PMID: 22461457
Ref: Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
PMID: 22472349
Ref: Chronic cadmium exposure in vitro causes acquisition of multiple tumor cell characteristics in human pancreatic epithelial cells.
PMID: 22626610
Ref: Nestin and other putative cancer stem cell markers in pancreatic cancer.
PMID: 22718289
Ref: Virotherapy using a novel chimeric oncolytic adenovirus prolongs survival in a human pancreatic cancer xenograft model.
PMID: 22853858
Ref: Pancreatic carcinoma cell lines reflect frequency and variability of cancer stem cell markers in clinical tissue.
PMID: 22948659
Ref: Stromal cell-derived factor 1alpha mediates resistance to mTOR-directed therapy in pancreatic cancer.
PMID: 22952422
Ref: Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells.
PMID: 22963768
Ref: CXCL12/CXCR4 protein signaling axis induces sonic hedgehog expression in pancreatic cancer cells via extracellular regulated kinase- and Akt kinase-mediated activation of nuclear factor kappaB: implications for bidirectional tumor-stromal interactions.
PMID: 22995914
Ref: Anti-CXCR4 monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticles in an application of MR molecular imaging of pancreatic cancer cell lines.
PMID: 23012484
Ref: CXCL12/CXCR4 axis plays pivotal roles in the organ-specific metastasis of pancreatic adenocarcinoma: A clinical study.
PMID: 23181100
Ref: MSH2 and CXCR4 involvement in malignant VIPoma.
PMID: 23231927
Ref: Pancreatic adenocarcinoma upregulated factor, a novel endothelial activator, promotes angiogenesis and vascular permeability.
PMID: 22907431
Ref: BRCA2 dysfunction promotes malignant transformation of pancreatic intraepithelial neoplasia.
PMID: 22934697
Ref: Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties.
PMID: 23338123
Ref: Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells.
PMID: 23338841
Ref: Towards a tailored therapy in pancreatic cancer.
PMID: 23650783
Ref: An intensified systemic trafficking of bone marrow-derived stem/progenitor cells in patients with pancreatic cancer.
PMID: 23672538
Ref: SDF-1alpha upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines.
PMID: 23712777
Ref: An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor kappaB- and hypoxia-inducible factor 1alpha-mediated up-regulation of CXCR4.
PMID: 23740244
Ref: A bioengineered metastatic pancreatic tumor model for mechanistic investigation of chemotherapeutic drugs.
PMID: 23747489
Ref: Cancer stem cell in the progression and therapy of pancreatic cancer.
PMID: 23747847
Ref: Drug-eluting scaffold to deliver chemotherapeutic medication for management of pancreatic cancer after surgery.
PMID: 23885173
Ref: Aberrant expression of CXCR4 and beta-catenin in pancreatic cancer.
PMID: 24023356
Ref: Role of CXCL12/CXCR4 signaling axis in pancreatic cancer.
PMID: 24033967
Ref: Adipose tissue-derived stem cells promote pancreatic cancer cell proliferation and invasion.
PMID: 24068191
Ref: Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes.
PMID: 24069258
Ref: CXCL12-CXCR4 promotes proliferation and invasion of pancreatic cancer cells.
PMID: 24175834
Ref: [Regulation effect of adipose-derived mesenchymal stem cells on pancreatic cancer cells].
PMID: 24330967
Ref: Hypoxia-independent gene expression mediated by SOX9 promotes aggressive pancreatic tumor biology.
PMID: 24302456
Ref: CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis.
PMID: 24594697
Ref: Analysis of dysregulation of immune system in pancreatic cancer based on gene expression profile.
PMID: 24619357
Ref: Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling.
PMID: 24785258
Ref: Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the expression of AR and CXCR4.
PMID: 24840182
Ref: Study on the relationship between CXCR4 expression and perineural invasion in pancreatic cancer.
PMID: 24998559
Ref: Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy.
PMID: 25240521
Ref: Nuclear receptors in pancreatic tumor cells.
PMID: 25503115
Ref: A concise review on the current understanding of pancreatic cancer stem cells.
PMID: 26451384
Ref: CXCR4 promotes GSK3beta expression in pancreatic cancer cells via the Akt pathway.
PMID: 25145299
Ref: Targeting cancer stem cells in solid tumors by vitamin D.
PMID: 25460302
Ref: Overexpression of Nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway.
PMID: 25557170
Ref: Stromal-derived factor-1alpha/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer.
PMID: 25605248
Ref: Paracrine SDF-1alpha signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells.
PMID: 25609203
Ref: CXCR4 over-expression and survival in cancer: a system review and meta-analysis.
PMID: 25669980
Ref: Exosomal lipids induce human pancreatic tumoral MiaPaCa-2 cells resistance through the CXCR4-SDF-1alpha signaling axis.
PMID: 25821841
Ref: Omeprazole Inhibits Pancreatic Cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor Pathway.
PMID: 25826687
Ref: The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
PMID: 25872129
Ref: Orthotopic inflammation-related pancreatic carcinogenesis in a wild-type mouse induced by combined application of caerulein and dimethylbenzanthracene.
PMID: 25916208
Ref: Gemcitabine triggers angiogenesis-promoting molecular signals in pancreatic cancer cells: Therapeutic implications.
PMID: 25970774
Ref: Chronic hyperglycemia induces trans-differentiation of human pancreatic stellate cells and enhances the malignant molecular communication with human pancreatic cancer cells.
PMID: 26010611
Ref: Application of chemokine receptor antagonist with stents reduces local inflammation and suppresses cancer growth.
PMID: 26044561
Ref: CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.
PMID: 26091099
Ref: GSK3beta mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway.
PMID: 26213494
Ref: Hypoxia promotes C-X-C chemokine receptor type 4 expression through microRNA-150 in pancreatic cancer cells.
PMID: 26622579
Ref: First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers.
PMID: 26769866
Ref: Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.
PMID: 27175473
Ref: Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis.
PMID: 27267632
Ref: The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR
PMID: 27289344
Ref: Pancreatic cancer stem cell markers and exosomes - the incentive push.
PMID: 27468191
Ref: Antitumor effects of herbal mixture extract in the pancreatic adenocarcinoma cell line PANC1.
PMID: 27599899
Ref: Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk.
PMID: 27609457
Ref: Radiation promotes epithelial-to-mesenchymal transition and invasion of pancreatic cancer cell by activating carcinoma-associated fibroblasts.
PMID: 27822411
Ref: Local and transient gene expression primes the liver to resist cancer metastasis.
PMID: 27831902
Ref: Hormophysa triquerta polyphenol, an elixir that deters CXCR4- and COX2-dependent dissemination destiny of treatment-resistant pancreatic cancer cells.
PMID: 27974694
Ref: Early pancreatic cancer lesions suppress pain through CXCL12-mediated chemoattraction of Schwann cells.
PMID: 27986950
Ref: Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis.
PMID: 28336327
Ref: Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease.
PMID: 28356064
Ref: Integrated clinicopathological features and gene microarray analysis of pancreatic neuroendocrine tumors.
PMID: 28479381
Ref: Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy.
PMID: 28549596
Ref: KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the Kras(G12D) p53(flox/flox) model.
PMID: 28581520
Ref: The pancreatic cancer microenvironment: A true double agent.
PMID: 28605029
Ref: Galeterone and its analogs inhibit Mnk-eIF4E axis, synergize with gemcitabine, impede pancreatic cancer cell migration, invasion and proliferation and inhibit tumor growth in mice.
PMID: 28881737
Ref: CXCR4/Let-7a Axis Regulates Metastasis and Chemoresistance of Pancreatic Cancer Cells Through Targeting HMGA2.
PMID: 28954272
Ref: Identification of molecular mechanisms of glutamine in pancreatic cancer.
PMID: 29163679
Ref: NFkappaB-Mediated Invasiveness in CD133(+) Pancreatic TICs Is Regulated by Autocrine and Paracrine Activation of IL1 Signaling.
PMID: 28970361
Ref: Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery.
PMID: 29187403
Ref: Mechanisms by which CXCR4/CXCL12 cause metastatic behavior in pancreatic cancer.
PMID: 29434873
Ref: Artemin regulates CXCR4 expression to induce migration and invasion in pancreatic cancer cells through activation of NF-kappaB signaling.
PMID: 29453972
Ref: Simvastatin inhibits sonic hedgehog signaling and stemness features of pancreatic cancer.
PMID: 29627496
Ref: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer.
PMID: 30337520